NNovo Nordisk Read More Novo Nordisk’s India Experiment Offers Hope as Pipeline Retrenches2026-05-11 India sales of Novo’s branded semaglutide drugs jumped 40% after patent expiry, as generics expanded the market. Meanwhile,…